Fulcrum Therapeutics, Inc. (NASDAQ: FULC) Faces Possible Securities Law Violations
Published [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] NEW YORK, NY – June 20, 2026 ( NEWMEDIAWIRE ) – Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Fulcrum Therapeutics, Inc. (“Fulcrum Therapeutics” or the “Company”) (NASDAQ: FULC). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a Fulcrum Therapeutics investor […]